August's reviewers of the month

Like most journals, BJUI relies on the hard work and dedication of its peer reviewers and we are grateful to them all. Each month the Editorial Team nominates peer reviewers whose reviews have stood out for their quality and timeliness and those selected as the best are highlighted on this page in recognition of their exceptional work.

Dr Luca Lambertini is an Academic Doctor based at the Careggi University Hospital in Florence (IT) with a clinical and academic interest in Uro-Oncology and Robot Assisted Surgery. He completed his medical degree at Univerity of Bologna (2013–18), followed by the Residency Programme at the Careggi University Hospital in Florence (IT) with research focused on Robot Assisted Radical Cystectomy with Intra Corporeal Neobladder. He attended a Research Fellowship at the University of Illinois in Chicago focused on Single Port surgery and Training programs. He is currently a Clinical Research Training Fellow undertaking his PhD at Careggi Hospital (IT) and UIH (2024+) in the development of a modular training program for Single Port Extraperitoneal Radical Prostatectomy.

Professor Arkadiusz Miernik, MD, PhD, FEBU, MHBA, is a senior urologist and academic based at the University Medical Center Freiburg, Germany, where he serves as Director of the Division of Urotechnology. He earned his medical degree from the Medical University of Vienna and completed his PhD and urology training in Freiburg. His clinical and scientific focus lies in minimally invasive urological surgery, innovations in endourology, and surgical education.

In 2015, he received the Maximilian Nitze Prize, the highest scientific award in German urology. Professor Miernik remains committed to advancing both clinical innovation and academic excellence in urology.

Dr Hari Vigneswaran is a physician–scientist with clinical training in urology and a focus on early cancer detection and translational diagnostics. He earned his medical degree from the Warren Alpert Medical School of Brown University and completed surgical training in urology at the University of Illinois at Chicago. He currently practices urology at Gundersen Health System in Wisconsin and is a clinical fellow at Karolinska University Hospital in Stockholm. He is also in his final year as a PhD candidate at the Department of Medical Epidemiology and Biostatistics (MEB) at Karolinska Institutet, where his research focuses on biomarker-driven strategies for prostate cancer screening and risk stratification. He currently serves as Chief Medical Officer at A3P, where he leads clinical development for precision diagnostic programs, including the implementation of Stockholm3.